Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q1 2024 · 10-Q
Revenue$59.00K$59.00K−24.4% vs Q1 2023 Net Income-$6.27M-$6.27MN/M vs Q1 2023 EPS Diluted-$0.41-$0.41N/M vs Q1 2023 Operating Income-$4,884,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
Free Cash Flowderived-$5,698,000N/M Margins · derivedOperating margin-8278.0%−3443.4 pt vs Q1 2023
Net margin-10627.1%+6363.9 pt vs Q1 2023
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end